{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:24:23Z","timestamp":1761953063863,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.3816\/clm.2006.n.052","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:11:10Z","timestamp":1221095470000},"page":"140-144","source":"Crossref","is-referenced-by-count":30,"title":["Response to Rituximab in Patients with Type II Cryoglobulinemia"],"prefix":"10.3816","volume":"7","author":[{"given":"Alan H.","family":"Bryce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Inwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Yasenchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaji K.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2006.n.052_bib1","first-page":"1157","article-title":"Rituximab for the treatment of type II mixed cryoglobulinemia","volume":"84","author":"Zaja","year":"1999","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2006.n.052_bib2","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib3","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/ndt\/gfh469","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.3816\/CLM.2006.n.052_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ndt\/gfh564","article-title":"Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab","volume":"20","author":"Koukoulaki","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.3816\/CLM.2006.n.052_bib5","first-page":"ELT33","article-title":"Inefficacy of rituximab in a case of low grade non-Hodgkin's lymphoma with cryoglobulinemia","volume":"87","author":"Baronciani","year":"2002","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2006.n.052_bib6","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajh.20207","article-title":"Initials increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenstr\u00f6m macroglobulinemia does not indicate failure of response","volume":"77","author":"Ghobrial","year":"2004","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2006.n.052_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3816\/CLM.2005.n.019","article-title":"Cold agglutinin disease and cryoglobulinemia","volume":"5","author":"Gertz","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLM.2006.n.052_bib9","series-title":"Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders","first-page":"227","article-title":"Cryoglobulinemia","author":"Dispenzieri","year":"2004"},{"key":"10.3816\/CLM.2006.n.052_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib11","first-page":"79","article-title":"The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders","volume":"27","author":"Treon","year":"2000","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2006.n.052_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1191\/0961203305lu2138oa","article-title":"Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases","volume":"14","author":"Chambers","year":"2005","journal-title":"Lupus"},{"key":"10.3816\/CLM.2006.n.052_bib13","first-page":"54","article-title":"Clonal B cell expansions in patients with essential mixed cryoglobulinaemia","volume":"76","author":"Perl","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.3816\/CLM.2006.n.052_bib14","first-page":"S141","article-title":"Lymphoproliferation in type II mixed cryoglobulinemia","volume":"13","author":"Monteverde","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.3816\/CLM.2006.n.052_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000207638","article-title":"A long-term follow-up study in essential cryoglobulinemia","volume":"61","author":"Invernizzi","year":"1979","journal-title":"Acta Haematol"},{"key":"10.3816\/CLM.2006.n.052_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/sonc.2003.50039","article-title":"Treatment recommendations in Waldenstr\u00f6m's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstr\u00f6m's Macroglobulinemia","volume":"30","author":"Gertz","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2006.n.052_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajh.20643","article-title":"Natural history and therapy of 66 patients with mixed cryoglobulinemia","volume":"81","author":"Bryce","year":"2006","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2006.n.052_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.3816\/CLM.2006.n.052_bib19","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De Re","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib20","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib21","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis","volume":"174","author":"Carbonari","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2006.n.052_bib22","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood.V97.6.1555","article-title":"The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection","volume":"97","author":"Zuckerman","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2006.n.052_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-200107000-00004","article-title":"Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center","volume":"80","author":"Trejo","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.3816\/CLM.2006.n.052_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/rheumatology\/41.3.290","article-title":"Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia","volume":"41","author":"Rieu","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.3816\/CLM.2006.n.052_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11864-000-0055-4","article-title":"Symptomatic cryoglobulinemia","volume":"1","author":"Dispenzieri","year":"2000","journal-title":"Curr Treat Options Oncol"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:10:19Z","timestamp":1588918219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011703146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S1557919011703146"],"URL":"https:\/\/doi.org\/10.3816\/clm.2006.n.052","relation":{},"ISSN":["1557-9190"],"issn-type":[{"type":"print","value":"1557-9190"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}